首页|水凝胶载药系统在骨肉瘤治疗中的研究进展

水凝胶载药系统在骨肉瘤治疗中的研究进展

扫码查看
骨肉瘤是儿童和青少年最常见的原发性恶性骨肿瘤,具有高度侵袭性,易在短时间内发生肺或全身转移,且复发率高,预后差.骨肉瘤的系统和规范治疗方案包括新辅助化疗、手术和术后放化疗.由于缺乏骨靶向性,传统的化疗药物往往不能在骨肉瘤部位积累,因此必须使用大剂量药物,进而不可避免地导致相关的全身不良反应.通过水凝胶载药系统进行局部给药,能够有效增高局部药物浓度、延长药物滞留时间、降低全身不良反应、减少给药频率、改善患者依从性.文章主要就近年来水凝胶载药系统在骨肉瘤治疗中的应用进行综述.
Advances on hydrogel drug delivery systems in the treatment of osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents,characterized by high invasiveness,rapid progression to pulmonary or systemic metastasis within a short period,high recurrence rates and poor prognosis.The systematic and standardized treatment regimen for osteosarcoma includes neoadjuvant chemotherapy,surgery,and postoperative radio-therapy and chemotherapy.Due to the lack of bone targeting,traditional chemotherapy drugs often cannot accumulate at the site of osteo-sarcoma,necessitating the use of high-dose medications,which inevitably leads to related systemic adverse reactions.Local administra-tion through hydrogel drug delivery systems can effectively increase local drug concentration,prolong drug retention time,reduce sys-temic adverse reactions,decrease frequency of administration,and improve patient compliance.This paper mainly reviews the applica-tion of hydrogel drug delivery systems in the treatment of osteosarcoma in recent years.

osteosarcomahydrogeldrug delivery systems

李志朋、章磊、黎承军

展开 >

210002南京,南京大学医学院附属金陵医院(东部战区总医院)骨科

骨肉瘤 水凝胶 载药系统

2024

医学研究生学报
南京军区南京总医院

医学研究生学报

CSTPCD北大核心
影响因子:1.652
ISSN:1008-8199
年,卷(期):2024.37(10)